The following video is part of our "Motley Fool Conversations" series in which David Williamson, health-care editor and analyst, and Brendan Byrnes, industrials editor and analyst, discuss topics across the investing world.
In today's edition, David and Brendan discuss some of the worst health-care stocks of 2011. These stocks fit relatively neatly into three categories: failure to launch, trial troubles, and home health-care scare. This video focuses on home health-care scare. The home healthcare sector was beaten down mercilessly in 2011 after an already poor showing in 2010. Given a DOJ and SEC investigation over billing practices, negative Medicare changes impacting business, and declining guidance figures, are these business doomed to failure? Or have they gotten so cheap that brighter days for investors are just over the horizon in 2012?
David Williamson and Brendan Byrnes do not own shares of the companies listed above. The Motley Fool owns shares of Almost Family. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
What's Juno Therapeutics Worth to Celgene?
Celgene may be considering a multibillion-dollar bid to acquire Juno.
PTC Inc. (PTC) Q1 2018 Earnings Conference Call Transcript
PTC earnings call for the period ending December 31, 2017.
Why Ascena Retail Group Inc. Stock Plunged 62% in 2017
The parent company of maurices just finished a tough year. Here's what investors need to know.